Specialty
Aesthetics Cardiology Cataract & Refractive Dermatology General Ophthalmology Glaucoma Neuro-Ophthalmology Oculoplastics Optometry Retina Women's Health View All Courses
Course Type
Evaluation Supplement Multimedia Webinar Podcast In-Person Multi-part Collection
Search
Login

KOL Knockout™ — Cataract Edition: Surgeons Battling for the Best Outcomes

By: Uday Devgan, MD, FACS, FRCS (Chair); Ravi D. Goel, MD; David A. Goldman, MD; Himani Goyal, MD; John A. Hovanesian, MD; Robert F. Melendez, MD, MBA; Zaina Al-Mohtaseb, MD; Denise M. Visco, MD, MBA

This course has expired. You can still review the content but course credit is no longer available.

Supplement Credits: 1.5

This continuing medical education (CME) activity captures content from a three live virtual symposia.

ACTIVITY DESCRIPTION
This supplement summarizes content from a series of three unique, live virtual symposia hosted by Uday Devgan, MD, FACS, FRCS. The game show-style quiz competition with real-time audience voting featured cataract-focused case studies and discussions regarding patient care and surgical approaches among seven key opinion leaders/contestants. The archived video series can be viewed here: https://evolvemeded.com/course-group/kol-knockoutcataract-edition-aberrometry-femtosecond-lasers-advanced-iols.

TARGET AUDIENCE
This certified CME activity is designed for ophthalmologists.

Expiration Date: Monday, October 31, 2022
Release Date: September 16, 2021

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Summarize the technology of femtosecond laser-assisted cataract surgery.
  • Explain how to incorporate femtosecond laser technology into cataract surgery techniques.
  • Establish when to incorporate intraoperative aberrometry to provide better refractive outcomes for cataract patients.
  • Evaluate patient lifestyles and expectations to improve intraocular lens choice.
  • Compare current and emerging technologies in advanced technology intraocular lenses

Accreditation and Designation Statement

Provided by 

Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT
Evolve Medical Education designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participation Method

In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS

Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+

Faculty and Disclosures

Uday Devgan, MD, FACS, FRCS (Chair)

Program Chair
Private Practice
Devgan Eye Surgery
Partner, Specialty Surgical Center
Chief of Ophthalmology
Olive View UCLA Medical Center

Los Angeles, California

Ravi D. Goel, MD

Comprehensive Ophthalmologist
Regional Eye Associates
Cherry Hill, NJ
Instructor
Wills Eye Hospital
Philadelphia, PA

David A. Goldman, MD

Private practice
Goldman Eye

Palm Beach Gardens, Florida

Himani Goyal, MD

Assistant Clinical Professor
Cataract, Cornea, & Refractive Surgery
NYU Langone Eye Center

John A. Hovanesian, MD

Clinical Instructor
Jules Stein Eye Institute
University of California Los Angeles
Owner
Harvard Eye Associates
Laguna Hills, California

Robert F. Melendez, MD, MBA

Founder and CEO
Juliette Eye Institute
Clinical Associate Professor
University of New Mexico
Albuquerque, New Mexico

Zaina Al-Mohtaseb, MD

Associate Professor of Ophthalmology
Associate Residency Program Director, Cornea, Cataract, and Refractive Surgery
Baylor College of Medicine
Houston, Texas

Denise M. Visco, MD, MBA

Medical Director and Founder
Eyes of York
York, Pennsylvania

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Uday Devgan, MD, FACS, FRCS, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Speaker: Bausch & Lomb and Novartis; Shareholder: Advanced Euclidean Solutions, CataractCoach.com, and LensGen.

Ravi D. Goel, MD, has had no financial agreement or affiliation during the past year.

David A. Goldman, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon Vision, Allergan, Bausch + Lomb, and Novartis. Speaker's Bureau: Allergan, and Eyevance. Stock/Shareholder: Alcon, Allergan, Johnson & Johnson, Kala Pharmaceuticals, Ocular Therapeutix, Stroma, and Tarsus.

Himani Goyal, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Carl Zeiss Meditec. Grant/Research Support: Research to Prevent Blindness.

John A. Hovanesian, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Advisory Board: 1-800-Doctors, Aerie Pharmaceuticals, Abbott Medical Optics, Blephex, Cord, Eyedetec, Glaukos, Guardian Health Sciences, Ingenoeye, IOP/Katena, Ivantis, Kala, MDBackline, Ocular Therapeutix, Omeros, ReVision Optics, Shire, Sight Sciences, Tearlab,  Tearfilm Innovations, Valeant, and Veracity. Consultant:  1-800-Doctors, Acufocus, Aerie Pharmaceuticals, Alcon Vision, Allegro Ophthalmics, Allergan, Abbott Medical Optics, BlephEx,  Eyedetec, Glaukos, Guardian Health Sciences, IOP/Katena, Ivantis, Kala, Novartis, Ocular Therapeutix, Omeros, ReVision Optics, Sarentis ophthalmics, Sensimed, Shire, Tearlab, Tearfilm Innovations, Valeant, and Veracity. Grant/Research: Aerie Pharmaceuticals, Abbott Medical Optics, Alcon Vision, Allergan, Cloudbreak Therapeutics, Cord, Eydetec, Glaukos, Ingenoeye, IOP/Katena, Novartis, Ocular Therapeutix, Omeros, ReVision Optics, Shire, Tearfilm Innovations, and Valeant. Stock/Shareholder/Equity: Alcon Vision, Alicia Surgery Center, Allegro Ophthalmics, Allergan, BlephEx, Eyedetec, Glaukos, Guardian Health Sciences, Harvard Eye Associates, Harvard Hearing, Ingenoeye, MDBackline, Novartis, Ocular Therapeutix, RxSight, Sarentis Ophthalmics, Sight Sciences, and Tearfilm Innovations. Royalties: SlackBooks and TLC: The Laser Center.

Robert F. Melendez, MD, MBA, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Speaker: Alcon Vision.

Zaina Al-Mohtaseb, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon Vision, Bausch + Lomb, Carl Zeiss Meditec, Corneagen, and Ocular Therapeutix.

Denise M. Visco, MD, MBA, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Bruder, Carl Ziess Meditec, Cassini, Lensar, Omeros, and Sun Pharmaceutical Industries. Grant/Research Support: Carl Ziess Meditec, Lensar, Omeros, Oyster Point Pharma, and Sun Pharmaceutical Industries. Speaker’s Bureau: Carl Ziess Meditec, Lensar, Omeros, and Sun Pharmaceutical Industries. Stock/Shareholder: Eyevance.

The Evolve staff and planners have no financial relationships with commercial interests. Michelle Dalton, writer, and Nisha Mukherjee, MD, peer reviewer, have no financial relationships with commercial interests.

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Cataract and Refractive Surgery Today, MillennialEYE, or Alcon Vision.

Begin Course